Get the Daily Brief
Latest Biotech News
Dana-Farber Develops AI-Driven Diagnostic Tool Revolutionizing Acute Leukemia
Researchers at Dana-Farber Cancer Institute introduced MARLIN, an innovative diagnostic technology combining DNA methylation profiling with machine learning to rapidly classify acute leukemia...
Phase Scientific Launches Large-Scale Urine-Based HPV Test Study in China
Phase Scientific initiated a prospective clinical study in China to assess the effectiveness of its urine-based human papillomavirus (HPV) DNA test for cervical cancer screening, targeting up to...
Pfizer Accelerates Obesity Pipeline with $4.9 Billion Metsera Acquisition
Pfizer has announced a definitive $4.9 billion cash acquisition of Metsera, a biotech focused on experimental injectable and oral obesity drugs. The deal, which includes contingent value rights...
Roche Sets Ambitious Goal to Become Top 3 Obesity Pharma by 2030
Roche unveiled a comprehensive strategy to become a top three player in the obesity market by 2030. CEO Teresa Graham emphasized the company’s robust pipeline, commercial capabilities, and...
Merck Wins FDA Nod for Injectable Keytruda: Faster Cancer Immunotherapy Delivery
Merck received FDA approval for Keytruda Qlex, an injectable form of its blockbuster cancer immunotherapy Keytruda. The new formulation allows dosing in minutes, compared to 30 minutes with the...
OGT Scores FDA Clearance for Companion Diagnostic in Acute Leukemia
British genomics company OGT secured FDA de novo authorization for its CytoCell KMT2A Breakapart FISH Probe Kit PDx as a companion diagnostic (CDx) for Syndax’s Revuforj (revumenib) in relapsed or...
Capsida Bio Halts STXBP1 Gene Therapy Trial After Patient Death
Capsida BioTherapeutics announced a voluntary hold on its SYNRGY Phase I/IIa clinical trial following the death of the first treated pediatric patient with STXBP1-related disorders, a rare...
MBX Biosciences Posts Positive Phase 2 Data in Hypoparathyroidism
MBX Biosciences reported that its once-weekly investigational hormone replacement drug canvuparatide achieved a 63% response rate in a Phase 2 trial for chronic hypoparathyroidism, outperforming...
Breakthrough Small Molecule Stabilizer May Treat Majority of Rare Disease Mutations
Researchers at the Centre for Genomic Regulation and Wellcome Sanger Institute published evidence that a single, FDA-approved small molecule drug can stabilize nearly all missense variants of the...
Genfit Terminates Acute Liver Failure Program After Serious Adverse Event
Genfit has discontinued development of its lead asset VS-01 in acute-on-chronic liver failure (ACLF) after a patient experienced peritonitis during a Phase 2 trial. The decision follows a data...
AI and Radioligand Collaboration: Eli Lilly Partners with Lila Bio
Eli Lilly has entered a global licensing and research collaboration with Lila Biologics to develop AI-designed radioligands for imaging and treatment of solid tumors. Using Lila's machine learning...
Texas Biotech Sector Gains Momentum with BIO’s National Spotlight
The Biotechnology Innovation Organization (BIO) spotlighted Texas during its 'BIO on the American Road' tour, praising the state’s rapid biotech growth and strong ecosystem. The sector, producing...
Merck’s Keytruda Injectable Wins FDA Nod for Faster Cancer Treatment
Merck secured FDA approval for Keytruda Qlex, an injectable formulation of its blockbuster cancer immunotherapy Keytruda. The new injectable version shortens administration time from 30 minutes to...
Seven Starling Secures $8M to Broaden Maternal Mental Health Reach
Seven Starling closed an $8 million funding round led by Rethink Impact with participation from Pear VC, Zeal Capital Partners, and March of Dimes among others. The capital injection aims to scale...
EmVenio Unifies Global Clinical Research Services Under One Brand
PCM Trials, EmVenio Research, and Clinical Trial Service have merged branding to establish EmVenio Clinical Research, creating a unified global organization to expand clinical trial accessibility....
TMolNet AI Platform Advances Molecular Property Prediction
Researchers Han, Tang, and Lu introduced TMolNet, a novel task-aware multimodal neural network designed to enhance molecular property prediction. TMolNet integrates various molecular data...
Circadian Disruption in Night Shift Workers Linked to Health Risks
Circadian immunologist Christoph Scheiermann detailed how night shift work causes a misalignment between biological clocks and environmental cues, increasing risks for cardiometabolic, autoimmune...
Researchers Uncover Ant Olfactory Precision Through Gene Regulation
Scientists revealed a genetic mechanism that enables ants to maintain highly specific olfactory senses by silencing neighboring receptor genes, preserving odor detection accuracy. This discovery...
Bio-Oil’s Aqueous Phase Yields High-Value Bioproducts
A landmark study led by Dias in Waste Biomass Valor explores the often-overlooked aqueous phase of bio-oil produced by biorefineries. Researchers demonstrate its potential to generate valuable...
Deep-Blue CsPbBr3 LEDs Reach Rec.2020 Standards
Researchers achieved a breakthrough in producing deep-blue light-emitting diodes (LEDs) using colloidal cesium lead bromide (CsPbBr3) nanoplatelets, meeting stringent Rec.2020 color standards for...